STAT

Opinion: On drug pricing, Trump could rely on bluster and bad ideas. But there’s a better alternative

In Trump's upcoming drug prices speech, will he regurgitate past sound bites or present constructive policy ideas?
Source: Pablo Martinez Monsivais/AP

As President Trump prepares to give a speech next week to address the issue of prescription drug prices, we wonder if we will witness the Trump of the presidential campaign, who slams the pharmaceutical industry for “getting away with murder” or a more measured, constructive Trump who recognizes the industry’s vital role in biomedical innovation and homes in on the role of payers and other middlemen?

The president, as we have all come to know, appears to devote far more attention to the politics of public policy than to the underlying policy itself. Indeed, he has tossed aside the script of formal speeches because the wonkish details offered by his aides were “a little boring.”

Although this is a disconcerting

You're reading a preview, sign up to read more.

More from STAT

STAT3 min read
Experimental Brain-controlled Hearing Aid Can Pick Out Voices In A Crowd
Researchers unveiled an experimental hearing aid that reads the mind, using artificial intelligence to separate the sounds of different speakers.
STAT3 min readSociety
A Smartphone App Could Help Diagnose Ear Infections More Accurately — And At Home
With a paper funnel and machine learning, a new smartphone app could help determine at home whether a child has an ear infection.
STAT4 min readSociety
Pharma Is Making Progress Addressing Global Health, But It’s Still A Mixed Bag
Drug makers are taking steps to reach people on very low incomes, but access programs are for just a few diseases.